Alliqua BioMedical, Inc. Announces the Closing of Approximately $2.8 Million Private Placement
Feb 28, 2017 12:35 pm UTC| Business
YARDLEY, Pa., Feb. 28, 2017 -- Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"), a regenerative technologies company committed to restoring tissue and rebuilding lives, today announced that investors...
Feb 28, 2017 12:30 pm UTC| Business
PALO ALTO, Calif., Feb. 28, 2017 -- Paysa, the only platform that uses artificial intelligence (AI) to deliver personalized career and hiring recommendations plus real-world salary insights, today announced the results...
FTI Consulting Reports Fourth Quarter and Full Year 2016 Financial Results
Feb 28, 2017 12:30 pm UTC| Business
Introduces 2017 Guidance WASHINGTON, Feb. 28, 2017 -- FTI Consulting, Inc. (NYSE:FCN) today released its financial results for the fourth quarter and full year ended December 31, 2016. Full Year 2016 Results ...
Alliqua BioMedical, Inc. Announces Termination of its Agreement to Acquire Soluble Systems, LLC
Feb 28, 2017 12:30 pm UTC| Business
YARDLEY, Pa., Feb. 28, 2017 -- Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"), a regenerative technologies company committed to restoring tissue and rebuilding lives, today announced the termination...
Cutera to Present at the 29th Annual ROTH Conference
Feb 28, 2017 12:30 pm UTC| Business
BRISBANE, Calif., Feb. 28, 2017 -- Cutera, Inc. (Nasdaq:CUTR), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, announced today that Ron Santilli, Chief Financial...
KemPharm, Inc. to Report Fourth Quarter and Year End 2016 Results
Feb 28, 2017 12:30 pm UTC| Business
Conference Call and Live Audio Webcast with Slide Presentation Scheduled forMarch 9th, 2017, 4:30 p.m. ET CORALVILLE, Iowa, Feb. 28, 2017 -- KemPharm, Inc. (NASDAQ:KMPH), a clinical-stage specialty pharmaceutical...
Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day
Feb 28, 2017 12:30 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Feb. 28, 2017 -- Cytokinetics, Inc. (Nasdaq:CYTK) today announced that it is joining the global initiative with the European Organisation for Rare Diseases (EURORDIS) and the National...